GB Patent

GB201103837D0 — Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid

Assigned to Oxagen Ltd · Expires 2011-04-20 · 15y expired

What this patent protects

Patent listed against Lynparza.

Drugs covered by this patent

Patent Metadata

Patent number
GB201103837D0
Jurisdiction
GB
Classification
—
Expires
2011-04-20
Drug substance claim
No
Drug product claim
No
Assignee
Oxagen Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.